Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

A Silk Coat for Diamonds Makes Sleek New Imaging and Drug Delivery Tool

Published: Tuesday, January 28, 2014
Last Updated: Tuesday, January 28, 2014
Bookmark and Share
New kind of tiny glowing particle could provide a novel technique for biological imaging and drug delivery.

The new particles, just tens of nanometers across, are made of diamond and covered in silk. They can be injected into living cells, and because they glow when illuminated with certain kinds of light, biologists can use them to peer inside cells and untangle the molecular circuitry that governs cellular behavior, or to study how cells react to a new drug. The silk-coated diamond particles could also potentially be used someday in the clinic, by allowing doctors to send infection-fighting antibiotics to a targeted area of the body.

A team of researchers from Australia and the United States describes this new hybrid diamond-silk material in a paper published today in The Optical Society’s (OSA) journal Biomedical Optics Express.

Nanodiamonds similar to those in this study have been explored previously for their potential medical uses, but this is the first time silk has been incorporated with nanodiamonds, said Asma Khalid of the University of Melbourne, who is the first author of the Biomedical Optics Express paper. "This nanodiamond-silk hybrid material is important due to the potential it offers to the fields of bioimaging, biosensing and drug delivery," she explained.

Diamonds are crystals of carbon. But they can be made with defects—other atoms inserted in the crystal structure—and these defects allow them to do tricks that flawless diamonds can’t, such as absorbing and reemitting light of certain wavelengths, a process called fluorescence. Because these fluorescent nanodiamonds are bright, stable, and harmless to living tissue – and can work at room temperature – researchers have been exploring their use in biological imaging and sensing. But the edges around the particles tend to be rough and may cause  the nanodiamonds to become trapped inside cell membranes.

Previously, other researchers have addressed this problem by coating the particles with lipids, a class of molecules found in fats and waxes. According to the new study, however, a better solution is to cover the nanodiamonds in silk, which is transparent, flexible, compatible with biological tissue, and biodegradable, so it won't leave any harmful byproducts inside the body.

When the researchers tested their new hybrid material, they found that the silk remains transparent, meaning that it does not block the glow of the nanodiamonds. They also discovered that the silk not only preserves the optical properties of the nanodiamonds, but it enhances their brightness by two to four times. Finally, the new material appears to be safe for use in the body: it left no damaging effects even after spending two weeks implanted inside living tissue, suggesting that it is nontoxic and non-inflammatory, the researchers say.

In the future, the team envisions a range of nanodiamond-silk structures that could help researchers improve techniques for fighting infections in targeted areas of the body. A thin film of the new substance, carrying drugs, could be implanted directly into an infected area, minimizing the patient’s exposure to the drugs. Silk can also be designed to degrade at a certain rate, which would allow clinicians to control the release of medications.

In addition to the University of Melbourne, the researchers are affiliated with the University of Sydney and the Silk Lab at Tufts University in Massachusetts.

Paper: “Synthesis and Characterization of Biocompatible Nanodiamond-Silk Hybrid Material,” Khalid, A. et al., Biomedical Optics Express, Vol. 5, Issue 2, pp. 596-608 (2014).

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos